Trial site
Hartford Healthcare
- 17running trials
- 9closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Melanoma5 trials
- Pancreatic cancer3 trials
- Atrial fibrillation2 trials
- Childhood cancers2 trials
- Gastric and oesophageal cancer2 trials
- Heart failure2 trials
- Obesity2 trials
- Parkinson disease2 trials
- Schizophrenia2 trials
- Ventricular tachycardia2 trials
- Bipolar disorder1 trial
- and 14 more
- Phase
- Phase 25 trials
- Phase 32 trials
- Phase 42 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting11 trials
- Completed6 trials
- Active, not recruiting5 trials
- Terminated3 trials
- Enrolling by invitation1 trial
- Suspended1 trial
- Lead sponsor
- Impulse Dynamics2 trials
- Memorial Sloan Kettering Cancer Center2 trials
- Regeneron Pharmaceuticals2 trials
- Yale University2 trials
- Aadi Bioscience, Inc.1 trial
- and 18 more
Running trials
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Obesity2 recruiting
- Pancreatic cancer2 recruiting
- Bipolar disorder1 recruiting
- Childhood cancers1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Peripheral artery disease1 recruiting
- Schizophrenia1 recruiting
- Triple-negative breast cancer1 recruiting
- Ventricular tachycardia1 recruiting
Closed trials
Completed
Completed
The 4th Trimester Initiative: The Impact of Parental Support on Pregnant Trainee Wellbeing
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Terminated
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Terminated
Completed
Completed
Recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026